Scientists review the current understanding of intestinal tropism of SARS-CoV-2 infection, its impact on mucosal function and immunology and summarize the effect of immune-suppression in patients with inflammatory bowel disease (IBD) on disease outcome of COVID-19
[Mucosal Immunology]
6445218 {6445218:KABJGNR8} apa 50 1 159279 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b7c7c4e5ed12c5be0c256f4ecaba40a1%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22KABJGNR8%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Weidinger%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWeidinger%2C%20C.%2C%20Hegazy%2C%20A.%20N.%2C%20Glauben%2C%20R.%2C%20%26amp%3B%20Siegmund%2C%20B.%20%282021%29.%20COVID-19%26%23x2014%3Bfrom%20mucosal%20immunology%20to%20IBD%20patients.%20%3Ci%3EMucosal%20Immunology%3C%5C%2Fi%3E%2C%201%26%23x2013%3B8.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41385-021-00384-9%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41385-021-00384-9%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DKABJGNR8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22COVID-19%5Cu2014from%20mucosal%20immunology%20to%20IBD%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carl%22%2C%22lastName%22%3A%22Weidinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%20Nabil%22%2C%22lastName%22%3A%22Hegazy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rainer%22%2C%22lastName%22%3A%22Glauben%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Britta%22%2C%22lastName%22%3A%22Siegmund%22%7D%5D%2C%22abstractNote%22%3A%22Viral%20infections%20with%20SARS-CoV-2%20can%20cause%20a%20multi-facetted%20disease%2C%20which%20is%20not%20only%20characterized%20by%20pneumonia%20and%20overwhelming%20systemic%20inflammatory%20immune%20responses%2C%20but%20which%20can%20also%20directly%20affect%20the%20digestive%20system%20and%20infect%20intestinal%20epithelial%20cells.%20Here%2C%20we%20review%20the%20current%20understanding%20of%20intestinal%20tropism%20of%20SARS-CoV-2%20infection%2C%20its%5Cu00a0impact%20on%20mucosal%20function%20and%20immunology%20and%20summarize%20the%20effect%20of%20immune-suppression%20in%20patients%20with%20inflammatory%20bowel%20disease%20%28IBD%29%20on%20disease%20outcome%20of%20COVID-19%20and%20discuss%20IBD-relevant%20implications%20for%20the%20clinical%20management%20of%20SARS-CoV-2%20infected%20individuals.%22%2C%22date%22%3A%222021-02-19%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41385-021-00384-9%22%2C%22ISSN%22%3A%221935-3456%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41385-021-00384-9%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-02-19T23%3A13%3A49Z%22%7D%7D%5D%7D
Weidinger, C., Hegazy, A. N., Glauben, R., & Siegmund, B. (2021). COVID-19—from mucosal immunology to IBD patients. Mucosal Immunology, 1–8. https://doi.org/10.1038/s41385-021-00384-9 Cite